Title |
Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials
|
---|---|
Published in |
Molecular Cancer, November 2016
|
DOI | 10.1186/s12943-016-0553-z |
Pubmed ID | |
Authors |
Yuko Tanabe, Hitoshi Ichikawa, Takashi Kohno, Hiroshi Yoshida, Takashi Kubo, Mamoru Kato, Satoru Iwasa, Atsushi Ochiai, Noboru Yamamoto, Yasuhiro Fujiwara, Kenji Tamura |
Abstract |
It is still controversial whether comprehensive genome screening of target molecules by next generation sequencing (NGS) is needed to increase clinical efficacy of investigational drugs or accelerate drug development, although several studies are being carried out. Therefore, we performed a prospective study to evaluate the feasibility of comprehensive gene screening in this setting. Our findings indicate that actionable alterations were identified in 45% of the analyzed patients, most frequently in those with breast cancer. Common actionable alterations were found in PIK3CA mutation, BRCA2 mutation, ERBB2 amplification, and CCND1 amplification. In total, 22% of the analyzed patients could be entered into phase I clinical trials, and 8% of them were treated with "matched" drugs. Among patients who received matched therapies, response and disease control rates were 33 and 78%, respectively. On the other hand, in the patients who received "non-matched" therapy, the objective response rate was 6%. We believe this data indicates that NGS-based molecular pre-screening is a potent platform for use before patient entry into phase I trials. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Montenegro | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Uruguay | 1 | 3% |
Unknown | 28 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 14% |
Other | 3 | 10% |
Student > Master | 3 | 10% |
Student > Bachelor | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Other | 1 | 3% |
Unknown | 14 | 48% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 21% |
Agricultural and Biological Sciences | 4 | 14% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Economics, Econometrics and Finance | 1 | 3% |
Psychology | 1 | 3% |
Other | 1 | 3% |
Unknown | 14 | 48% |